Position in STTK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,910,880
+$3,168,341 QoQ
Shares Held
763,745
+60.0% QoQ
Ownership
0.996%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in STTK Over Time
Shares Held
Position Value (USD)
Derivatives in STTK
reported options exposure · as of Mar 31, 2024CallValue
$894,000
CallShares
100,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $3,884,102,157 across 342 Biotechnology names. STTK ranks #163 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 5 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 6 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,051,506 | $78,957,585 | |
| 8 | ABVX |
Abivax S.A.
|
605,992 | $67,477,209 |
All Filings in STTK
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,910,880 | 763,745 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,742,539 | 477,408 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,651,253 | 690,901 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $667,858 | 843,256 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $287,468 | 302,598 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $243,468 | 201,214 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $512,653 | 146,892 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $374,080 | 96,912 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $894,000 | 100,000 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $5,474,712 | 612,384 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $75,905 | 10,646 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $80,432 | 52,916 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $175,281 | 56,180 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $174 | 59,280 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $216 | 94,119 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $492,704 | 182,483 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,071,941 | 264,025 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $353,533 | 82,989 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,099,556 | 481,734 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,741,762 | 134,532 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $416,202 | 14,234 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||